Neutralization of HIV-1 by an IgM antibody expressing the VRC01 V region

被引:0
|
作者
Olshevsky, U. [1 ]
Pegu, A. [1 ]
McTamney, P. [1 ]
Yang, Z. [1 ]
McKee, K. [1 ]
Mascola, J. [1 ]
Nabel, G. [1 ]
机构
[1] NIAID, NIH, Bethesda, MD 20892 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:A155 / A155
页数:1
相关论文
共 50 条
  • [1] Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01
    Li, Yuxing
    O'Dell, Sijy
    Walker, Laura M.
    Wu, Xueling
    Guenaga, Javier
    Feng, Yu
    Schmidt, Stephen D.
    McKee, Krisha
    Louder, Mark K.
    Ledgerwood, Julie E.
    Graham, Barney S.
    Haynes, Barton F.
    Burton, Dennis R.
    Wyatt, Richard T.
    Mascola, John R.
    [J]. JOURNAL OF VIROLOGY, 2011, 85 (17) : 8954 - 8967
  • [2] Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
    Zhou, Tongqing
    Georgiev, Ivelin
    Wu, Xueling
    Yang, Zhi-Yong
    Dai, Kaifan
    Finzi, Andres
    Kwon, Young Do
    Scheid, Johannes F.
    Shi, Wei
    Xu, Ling
    Yang, Yongping
    Zhu, Jiang
    Nussenzweig, Michel C.
    Sodroski, Joseph
    Shapiro, Lawrence
    Nabel, Gary J.
    Mascola, John R.
    Kwong, Peter D.
    [J]. SCIENCE, 2010, 329 (5993) : 811 - 817
  • [3] Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials
    Mkhize, Nonhlanhla N.
    Yssel, Anna
    Kaldine, Haajira
    van Dorsten, Rebecca T.
    Davis, Amanda S.
    Beaume, Nicolas
    Matten, David
    Lambson, Bronwen
    Modise, Tandile
    Kgagudi, Prudence
    York, Talita
    Westfall, Dylan H.
    Giorgi, Elena E.
    Korber, Bette
    Anthony, Colin
    Mapengo, Rutendo E.
    Bekker, Valerie
    Domin, Elizabeth
    Eaton, Amanda
    Deng, Wenjie
    DeCamp, Allan
    Huang, Yunda
    Gilbert, Peter B.
    Gwashu-Nyangiwe, Asanda
    Thebus, Ruwayhida
    Ndabambi, Nonkululeko
    Mielke, Dieter
    Mgodi, Nyaradzo
    Karuna, Shelly
    Edupuganti, Srilatha
    Seaman, Michael S.
    Corey, Lawrence
    Cohen, Myron S.
    Hural, John
    McElrath, M. Juliana
    Mullins, James I.
    Montefiori, David
    Moore, Penny L.
    Williamson, Carolyn
    Morris, Lynn
    [J]. PLOS PATHOGENS, 2023, 19 (06)
  • [4] VRC01 antibody prevention of HIV
    Corey, L.
    Gilbert, P. B.
    Mgodi, N. M.
    Edupuganti, S.
    Cohen, M. S.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24
  • [5] Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
    Ledgerwood, J. E.
    Coates, E. E.
    Yamshchikov, G.
    Saunders, J. G.
    Holman, L.
    Enama, M. E.
    DeZure, A.
    Lynch, R. M.
    Gordon, I.
    Plummer, S.
    Hendel, C. S.
    Pegu, A.
    Conan-Cibotti, M.
    Sitar, S.
    Bailer, R. T.
    Narpala, S.
    McDermott, A.
    Louder, M.
    O'Dell, S.
    Mohan, S.
    Pandey, J. P.
    Schwartz, R. M.
    Hu, Z.
    Koup, R. A.
    Capparelli, E.
    Mascola, J. R.
    Graham, B. S.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 182 (03): : 289 - 301
  • [6] Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features
    Magaret, Craig A.
    Benkeser, David C.
    Williamson, Brian D.
    Borate, Bhavesh R.
    Carpp, Lindsay N.
    Georgiev, Ivelin S.
    Setliff, Ian
    Dingens, Adam S.
    Simon, Noah
    Carone, Marco
    Simpkins, Christopher
    Montefiori, David
    Alter, Galit
    Yu, Wen-Han
    Juraska, Michal
    Edlefsen, Paul T.
    Karuna, Shelly
    Mgodi, Nyaradzo M.
    Edugupanti, Srilatha
    Gilbert, Peter B.
    [J]. PLOS COMPUTATIONAL BIOLOGY, 2019, 15 (04) : 1 - 35
  • [7] Prediction of VRC01 Neutralization Sensitivity by HIV-1 gp160 Sequence Features
    Magaret, Craig A.
    Williamson, Brian D.
    Borate, Bhavesh
    Carpp, Lindsay
    Georgiev, Ivelin
    Setliff, Ian
    Dingens, Adam S.
    Benkesser, David C.
    Simon, Noah
    Carone, Marco
    Montefiori, David
    Alter, Galit
    Yu, Wen-Han
    Juraska, Michal
    Edlefsen, Paul T.
    Karuna, Shelly
    Mgodi, Nyaradzo M.
    Edugupanti, Srilatha
    Gilbert, Peter B.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 344 - 344
  • [8] Selection of Peptide Mimics of HIV-1 Epitope Recognized by Neutralizing Antibody VRC01
    Chikaev, Anton N.
    Bakulina, Anastasiya Yu.
    Burdick, Ryan C.
    Karpenko, Larisa I.
    Pathak, Vinay K.
    Ilyichev, Alexander A.
    [J]. PLOS ONE, 2015, 10 (03):
  • [9] V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
    D Guo
    X Shi
    K Arledge
    D Song
    L Jiang
    L Fu
    S Zhang
    X Wang
    L Zhang
    [J]. Retrovirology, 9 (Suppl 2)
  • [10] Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants
    Huang, Yunda
    Zhang, Lily
    Eaton, Amanda
    Mkhize, Nonhlanhla N.
    Carpp, Lindsay N.
    Rudnicki, Erika
    DeCamp, Allan
    Juraska, Michal
    Randhawa, April
    McDermott, Adrian
    Ledgerwood, Julie
    Andrew, Philip
    Karuna, Shelly
    Edupuganti, Srilatha
    Mgodi, Nyaradzo
    Cohen, Myron
    Corey, Lawrence
    Mascola, John
    Gilbert, Peter B.
    Morris, Lynn
    Montefiori, David C.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)